HEALINE

Weekly Summary -- December 21, 2018

Friday, Dec. 21, 2018 (Pharmacist's Briefing) -- Here are what Pharmacist's Briefing editors consider the most important developments for the week of December 21, 2018

Protein Portions: Feeling Satisfied on Fewer Calories

TUESDAY, Dec. 18, 2018 (Pharmacist's Briefing) -- Eating protein every day is important for good health. While it can come from animal and/or plant sources, the amount of protein we need is rather small -- just 5 to 7 "ounce equivalents," according to the U.S. Department of Agriculture.

Read More

Today's More Potent Pot Means Higher Odds for Dependence: Study

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- Pot's increasing potency could make it more likely that toking will interfere with users' lives, a new study argues.

Read More

Fast Facts for Men (and Women) About High Cholesterol

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- High cholesterol, a serious risk factor for heart disease, can affect both men and women, and it's common for cholesterol levels to rise with age. But it's often a problem for men earlier in life than for women.

Read More

Migraine's 'Silver Lining': Lowered Risk for Diabetes?

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- A study of more than 74,000 French women has turned up an unexpected finding: Those who suffer from migraines have a significantly lower risk for type 2 diabetes.

Read More

Docs Should Screen for Depression During, After Pregnancy

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- Doctors should screen women for depression during and after pregnancy, the American Academy of Pediatrics (AAP) says in an updated policy statement.

Read More

Chest CT Can ID Respiratory AE Risk in RA Patients on Biologics

TUESDAY, Dec. 18, 2018 (Pharmacist's Briefing) -- Chest computed tomography (CT) findings may identify risk factors for respiratory adverse events (RAEs) in rheumatoid arthritis (RA) patients undergoing long-term biological therapy, according to a study recently published in the International Journal of Rheumatic Diseases.

Read More

More U.S. Teens Are Vaping, but Use of Opioids, Alcohol Falling

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- Vaping among American teenagers increased dramatically in 2018, with nearly two of every five high school seniors reporting they had tried an electronic cigarette during the past year, according to the latest Monitoring the Future survey funded by the U.S. National Institute on Drug Abuse.

Read More

Risk for Zoster Up Before Dx, During Tx of Hematologic Cancer

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- The risk for herpes zoster (zoster) is elevated during the two years preceding diagnosis and during treatment of hematological cancer, according to a study published online Dec. 13 in the Journal of Infectious Diseases.

Read More

Solriamfetol Feasible for Sleep Apnea-Related Tiredness

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- Solriamfetol therapy, compared with placebo, results in improvements in wakefulness and sleepiness measures in patients with excessive sleepiness due to obstructive sleep apnea (OSA), according to a study published online Dec. 6 in the American Journal of Respiratory and Critical Care Medicine.

Read More

Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- For treatment of human papillomavirus (HPV)-positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control, according to a study recently published in The Lancet.

Read More

Routine Supplements to Prevent Chronic Disease Not Advised

TUESDAY, Dec. 18, 2018 (Pharmacist's Briefing) -- Routine use of vitamin and mineral supplements to prevent chronic disease is not recommended, according to an Academy of Nutrition and Dietetics position paper published in the November issue of the Journal of the Academy of Nutrition and Dietetics.

Read More

Type 2 Diabetes Risk Lower in Women With Active Migraine

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- Women with active migraine have a lower risk for type 2 diabetes, according to a study published online Dec. 17 in JAMA Neurology.

Read More

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine.

Read More

Some With Type 2 Diabetes Inappropriately Monitoring Blood Glucose

MONDAY, Dec. 17, 2018 (Pharmacist's Briefing) -- A considerable proportion of patients with type 2 diabetes may be self-monitoring blood glucose inappropriately, according to a research letter published online Dec. 10 in JAMA Internal Medicine.

Read More

Copyright © 2019 HealthDay. All rights reserved.